Search details
1.
Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer.
Br J Cancer
; 110(12): 2975-84, 2014 Jun 10.
Article
in English
| MEDLINE | ID: mdl-24867692
2.
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer.
Br J Cancer
; 106(11): 1779-89, 2012 May 22.
Article
in English
| MEDLINE | ID: mdl-22549178
3.
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.
Br J Cancer
; 103(3): 401-10, 2010 Jul 27.
Article
in English
| MEDLINE | ID: mdl-20628393
4.
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.
Ann Oncol
; 21(6): 1254-1261, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-19858088
5.
Implantable biosensors and their contribution to the future of precision medicine.
Vet J
; 239: 21-29, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30197105
6.
Correlation between the molecular weight and potency of polar compounds which induce the differentiation of HL-60 human promyelocytic leukemia cells.
Cancer Res
; 47(1): 140-4, 1987 Jan 01.
Article
in English
| MEDLINE | ID: mdl-3466688
7.
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.
Cancer Res
; 61(5): 2169-76, 2001 Mar 01.
Article
in English
| MEDLINE | ID: mdl-11280782
8.
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
Cancer Res
; 47(22): 5846-52, 1987 Nov 15.
Article
in English
| MEDLINE | ID: mdl-3664486
9.
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Cancer Res
; 48(21): 6161-5, 1988 Nov 01.
Article
in English
| MEDLINE | ID: mdl-3167862
10.
Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.
Cancer Res
; 45(7): 3008-13, 1985 Jul.
Article
in English
| MEDLINE | ID: mdl-4005840
11.
Characterization and properties of nine human ovarian adenocarcinoma cell lines.
Cancer Res
; 48(21): 6166-72, 1988 Nov 01.
Article
in English
| MEDLINE | ID: mdl-3167863
12.
Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?
Ann Oncol
; 21(6): 1375, 2010 Jun.
Article
in English
| MEDLINE | ID: mdl-20215137
13.
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell lines.
Eur J Cancer
; 41(11): 1637-44, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15953713
14.
Expression of the heat shock protein HSP27 in human ovarian cancer.
Clin Cancer Res
; 1(12): 1603-9, 1995 Dec.
Article
in English
| MEDLINE | ID: mdl-9815962
15.
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.
Clin Cancer Res
; 4(9): 2245-51, 1998 Sep.
Article
in English
| MEDLINE | ID: mdl-9748145
16.
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features.
Clin Cancer Res
; 2(1): 201-6, 1996 Jan.
Article
in English
| MEDLINE | ID: mdl-9816107
17.
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer.
Clin Cancer Res
; 1(9): 945-53, 1995 Sep.
Article
in English
| MEDLINE | ID: mdl-9816065
18.
Endothelin expression and responsiveness in human ovarian carcinoma cell lines.
Eur J Cancer
; 33(4): 661-8, 1997 Apr.
Article
in English
| MEDLINE | ID: mdl-9274451
19.
Paracrine regulation of ovarian cancer by endothelin.
Eur J Cancer
; 35(9): 1381-7, 1999 Sep.
Article
in English
| MEDLINE | ID: mdl-10658531
20.
Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes.
Eur J Cancer
; 31A(6): 969-73, 1995 Jun.
Article
in English
| MEDLINE | ID: mdl-7646930